Contract 75N95020C00034
New York Stem Cell Foundation Inc · Department Of Health And Human Services · September 26, 2020
New York Stem Cell Foundation Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 26, 2020 for $414,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in New York, NY. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 21, 2021.
Contract details
- PIID
- 75N95020C00034
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Medical- Laboratory Testing
- Place of performance
- New York, NY
- First action
- September 26, 2020
- Latest action
- January 21, 2021
Description
EXPANSION, DIFFERENTIATION, AND VALIDATION OF NEURAL PROGENITOR CELLS (NPCS) FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS)
Modification timeline
-
January 21, 2021Mod P00001$0
-
September 26, 2020Base award$414.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95020C00034?
Contract 75N95020C00034 is a federal contract awarded to New York Stem Cell Foundation Inc by Department Of Health And Human Services on September 26, 2020 for $414,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N95020C00034?
New York Stem Cell Foundation Inc won contract 75N95020C00034 from Department Of Health And Human Services.
How much is contract 75N95020C00034 worth?
Contract 75N95020C00034 has obligated $414,000 to date.